Clinical outcomes following Cochlear™ BIA300 bone anchored hearing aid implantation in children

Fussey, Jonathan; Harterink, Emilie; Gill, J.S.; Child-Hymas, Anne; McDermott, Ann-Louise

doi:10.1016/j.ijporl.2018.05.033

Cited by 19 publications

(22 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Ricci et al [17] analyzed 49 BAHA devices that resulted in a 6.1% complication rate. Fussey et al [18] noted that 35% of 52 patients implanted with BIA300 required revision surgery.…”

Section: Discussionmentioning

confidence: 99%

Medical, Technical and Audiological Outcomes of Hearing Rehabilitation with the Bonebridge Transcutaneous Bone-Conduction Implant: A Single-Center Experience

Brkic

Riss

Scheuba

et al. 2019

JCM

View full text Add to dashboard Cite

Bone-conduction implants are a standard therapeutic option for patients with conductive, unilateral, or mixed hearing loss who either do not tolerate conventional hearing aids or can benefit from surgery. The aim of this study was to evaluate long-term medical and technical outcomes, and audiological results with the Bonebridge transcutaneous bone-conduction implant. This retrospective study included all patients implanted with a bone-conduction hearing implant at a tertiary medical referral center between March 2012 and October 2018. Medical and technical outcomes included the mean length of implant usage, medical and technical complications (skin and wound infection, lack of benefit, technical failure), explantations and revisions, coupling approaches, implant failure rate, implant survival and the implant loss for added follow-up years. Auditory results were measured by functional hearing gain and the Freiburger monosyllabic test at 65 dB sound pressure level. Sixty-four patients were included in the study; five of these were implanted bilaterally (69 devices). Five unilaterally implanted patients were lost to follow-up. The mean follow-up was 27.1 months (range: 0.2 months–6.3 years). The mean implant usage was 25.9 months (range: 0.2 months–6.3 years). Fifty-seven implants (89.1%) were in use at the end of the follow-up period. Complications occurred in six ears (9.4%). Five implants (7.8%) were explanted without reimplantation. Device failure occurred in one implant (1.6%), which was possibly caused by recurrent head trauma. The rate of implant loss due to technical device failure (damage to device) was 1 per 72 follow-up years. The mean improvement on the Freiburger monosyllabic test (52.1%, p = 0.0001), and in functional hearing gain across frequencies (26.5 dB, p = 0.0001) was significant. This single-center follow-up reveals the medical and technical reliability of a transcutaneous bone-conduction implant for hearing rehabilitation because complication and revision rates were low. The majority of patients still used the device at the end of the observation period. Implantation resulted in favorable hearing outcomes in comparison to that of unaided conditions. Cautious patient selection mainly regarding co-morbidities, the history of chronic otologic diseases and proper surgical technique seems to be crucial in reducing complications.

show abstract

“…Ricci et al [17] analyzed 49 BAHA devices that resulted in a 6.1% complication rate. Fussey et al [18] noted that 35% of 52 patients implanted with BIA300 required revision surgery.…”

Section: Discussionmentioning

confidence: 99%

Medical, Technical and Audiological Outcomes of Hearing Rehabilitation with the Bonebridge Transcutaneous Bone-Conduction Implant: A Single-Center Experience

Brkic

Riss

Scheuba

et al. 2019

JCM

View full text Add to dashboard Cite

show abstract

“…3 This preliminary study suggests that complications of the OSIA2 are low in contrast to percutaneous bone conduction devices, in which soft tissue complications can be seen in approximately 50% of pediatric users even with typical durations of daily use. 1,3,4 SUMMARY AND CONCLUSION Surgical application of the OSIA2 device in a representative group of young children was feasible and demonstrated low rates of complication. Miniaturization of bone conduction technologies, along with increasing experience in their surgical application, may help to reduce the developmental consequences of hearing loss by allowing early intervention 5 and provision of bilateral hearing with fewer complications.…”

Section: Discussionmentioning

confidence: 99%

Surgical Considerations for an Osseointegrated Steady State Implant (OSIA2®) in Children

et al. 2021

View full text Add to dashboard Cite

“…The same solution was effective in resolving the skin infection in the one participant who experienced this problem in this study. By contrast, infections and inflammation around percutaneous BC devices can persist and recur in roughly 50% of pediatric users even with typical durations of daily use (1,7,8).…”

Section: Discussionmentioning

confidence: 99%

“…Surgical devices are either percutaneous, penetrating the skin, or transcutaneous without skin penetration. Percutaneous devices provide efficient directly driven skull vibration by physically coupling vibrations generated by the external equipment to the internal components; they can be used for mixed hearing loss of moderately severe degree (5) and in young children (6) but are prone to infection in children (1,7,8). The first transcutaneous devices generated vibrations from the external component that transferred across the skin to the internal component (passive).…”

mentioning

confidence: 99%

First Generation Osseointegrated Steady State Implant Benefits in Children With Hearing Loss

Gordon

Papsin

Feness

et al. 2021

Otology &Amp; Neurotology

View full text Add to dashboard Cite

Objective:To assess outcomes of a new Osseointegrated Steady State Implant (OSSI) for bone conduction in adolescents.Method:In an initial trial, 14 adolescents (14.5 years of age, SD = 2.22) were provided with an OSSI; unilateral OSSI (n = 13), bilateral OSSI in sequential surgeries (n = 1). Outcomes measured were surgical duration, complications, hearing thresholds, speech perception and self-reported hearing benefits using the Speech and Spatial Quality of Hearing Questionnaire.Results:The surgical times were mean 93.6 minutes (SD = 33.3). Surgery was slightly longer in three adolescents who required skin flap reduction (n = 1) or significant bone polishing (n = 2) (121.33 minutes, SD = 8.14). Adverse events occurred in two adolescents post-implant poor external device retention in one child requiring revision flap reduction and inflammation at the incision site due to magnet overuse in another. The “Digital Link Calibration” measure was a good proxy predictor of the strength of magnet required for external device adherence (p = 0.002). The OSSI increased audibility in the implanted ear by mean 31.48 dB HL (SE = 1.58). Aided thresholds were best at 1 kHz (mean 25.33 dB HL, SD = 22.60) and only slightly poorer at 3000 and 4000 Hz (estimate decrease = 8.33 dB HL, SE = 3.54), reflecting good auditory sensitivity even at high frequencies. Speech perception when using the new device alone was good (89.67%, SD = 7.84%) and self-reported hearing by participants and parents improved in all domains assessed by the Speech and Spatial Quality of Hearing Questionnaire (estimate = 1.90 points, SE = 0.25, p < 0.0001).Conclusion:The OSSI provides hearing benefits with surgical safety in a carefully selected cohort of adolescents.

show abstract

Clinical outcomes following Cochlear™ BIA300 bone anchored hearing aid implantation in children

Cited by 19 publications

References 17 publications

Medical, Technical and Audiological Outcomes of Hearing Rehabilitation with the Bonebridge Transcutaneous Bone-Conduction Implant: A Single-Center Experience

Medical, Technical and Audiological Outcomes of Hearing Rehabilitation with the Bonebridge Transcutaneous Bone-Conduction Implant: A Single-Center Experience

Surgical Considerations for an Osseointegrated Steady State Implant (OSIA2®) in Children

First Generation Osseointegrated Steady State Implant Benefits in Children With Hearing Loss

Contact Info

Product

Resources

About